Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-06-021300
Filing Date
2006-05-17
Accepted
2006-05-17 16:46:13
Documents
4
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 v043544_10ka.htm 10-K/A 42860
2 v043544_ex10-21.htm EX-10.21 289365
3 v043544_ex31-1.htm EX-31.1 6726
4 v043544_ex31-2.htm EX-31.2 6916
  Complete submission text file 0001144204-06-021300.txt   347178
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

EIN.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30929 | Film No.: 06849595
SIC: 2834 Pharmaceutical Preparations